Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Silver sulfadiazine is a topical sulfonamide antibiotic that acts on the bacterial cell wall and cell membrane; approved for the treatment of burns. Silver sulfadiazine is a sulfa derivative topical antibacterial used primarily on second- and third-degree burns.
- Mechanism
- Curator reviewed
Studies utilizing radioactive micronized silver sulfadiazine, electron microscopy, and biochemical techniques have revealed that the mechanism of action of silver sulfadiazine on bacteria differs from silver nitrate and sodium sulfadiazine. Silver sulfadiazine acts only on the cell membrane and cell wall to produce its bactericidal effect. A specific mechanism of action has not been determined, but silver sulfadiazine's effectiveness may possibly be from a synergistic interaction, or the action of each component. Silver is a biocide, which binds to a broad range of targets. Silver ions bind to nucleophilic amino acids, as well as sulfhydryl, amino, imidazole, phosphate, and carboxyl groups in proteins, causing protein denaturation and enzyme inhibition. Silver binds to surface membranes and proteins, causing proton leaks in the membrane, leading to cell death. Sulfadiazine is a competitive inhibitor of bacterial para-aminobenzoic acid (PABA), a substrate of the enzyme dihydropteroate synthetase. The inhibited reaction is necessary in these organisms for the synthesis of folic acid.
- Primary indication
- Indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second- and third-degree burns.Curator reviewed · 5 structured indications
- Formula / weight
- C10H9AgN4O2S · 357.137 g/mol (avg)
- First approval
- Canada, 2000 · United States, 1973
- Also known as
- Silver sulfadiazinate · Silver sulphadiazine · Sulfadiazine silver · Sulfadiazine, silver
- Brand names
- Silvadene
- Ssd
- Thermazene
Resolves to
UEJSSZHHYBHCEL-UHFFFAOYSA-NSMILES[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1What you can answer from here — as of June 15, 2026
Which drugs share a target with Silver sulfadiazine, and which of those have an active Phase 3 trial?